UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 470

Sortiert nach

Peripheral blood eosinophils and other non‐invasive biomarkers can monitor treatment response in eosinophilic oesophagitis

Alimentary pharmacology & therapeutics, 2015-11, Vol.42 (9), p.1122-1130

2015

Volltextzugriff (PDF)

The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract

Alimentary pharmacology & therapeutics, 2010-03, Vol.31 (5), p.548-552

2010

Volltextzugriff (PDF)

Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis

Alimentary pharmacology & therapeutics, 2016-04, Vol.43 (7), p.825-830

2016

Volltextzugriff (PDF)

Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018

Clinical microbiology and infection, 2020-02, Vol.26 (2), p.235-239

2020

Volltextzugriff (PDF)

Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group

Journal of Crohn's and colitis, 2012-10, Vol.6 (9), p.932-945

2012

Volltextzugriff (PDF)

Induction of Intestinal P-glycoprotein by St John's Wort Reduces the Oral Bioavailability of Talinolol

Clinical pharmacology and therapeutics, 2007-05, Vol.81 (5), p.669-678

2007

Volltextzugriff (PDF)

Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagus

Endoscopy, 2010-06, Vol.42 (6), p.435

2010

Volltextzugriff (PDF)

Diagnostic and therapeutic management of helicobacter pylori: a survey among German gastroenterologists in private practice

Zeitschrift fur Gastroenterologie, 2016-10, Vol.54 (10), p.1130

2016

Volltextzugriff (PDF)

Randomized trial of rifabutin‐based triple therapy and high‐dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin

Alimentary pharmacology & therapeutics, 2006-07, Vol.24 (2), p.395-403

2006

Volltextzugriff (PDF)

Clinical symptom tool that raises the index of suspicion for eosinophilic oesophagitis in adults and drives earlier biopsy for definitive diagnosis

Alimentary pharmacology & therapeutics, 2017-02, Vol.45 (3), p.417-426

2017

Volltextzugriff (PDF)

Letter: multivariate clinical model for eosinophilic oesophagitis – is this generalisable to a general population? Authors’ reply

Alimentary pharmacology & therapeutics, 2017-03, Vol.45 (6), p.861-861

2017

Volltextzugriff (PDF)

Microscopic colitis: clinical presentation, treatment and outcome of 494 patients

Zeitschrift fur Gastroenterologie, 2014-09, Vol.52 (9), p.1062

2014

Volltextzugriff (PDF)

Long‐term follow‐up of collagenous colitis after induction of clinical remission with budesonide

Alimentary pharmacology & therapeutics, 2005-12, Vol.22 (11‐12), p.1115-1119

2005

Volltextzugriff (PDF)

Less favorable clinical outcome after diagnostic and interventional double balloon enteroscopy in patients with suspected small-bowel bleeding?

Endoscopy, 2008-09, Vol.40 (9), p.731

2008

Volltextzugriff (PDF)

Complete Remission of Primary High-Grade B-Cell Gastric Lymphoma After Cure of Helicobacter pylori Infection

Journal of clinical oncology, 2001-04, Vol.19 (7), p.2041-2048

2001

Volltextzugriff (PDF)

Eosinophilic Esophagitis - Update - Pathogenesis, Diagnosis and Therapy

Laryngo- rhino- otologie, 2017-01, Vol.96 (1), p.11

2017

Volltextzugriff (PDF)

Microscopic colitis--new insights relevant to clinical practice

Zeitschrift fur Gastroenterologie, 2013-12, Vol.51 (12), p.1389

2013

Volltextzugriff (PDF)

Successful treatment of Lichen planus esophagitis with topical budesonide

Zeitschrift fur Gastroenterologie, 2012-10, Vol.50 (10), p.1104

2012

Volltextzugriff (PDF)

Intragastric acidity during administration of generic omeprazole or esomeprazole – a randomised, two‐way crossover study including CYP2C19 genotyping

Alimentary pharmacology & therapeutics, 2011-02, Vol.33 (4), p.471-476

2011

Volltextzugriff (PDF)

Eosinophilic esophagitis

Deutsche medizinische Wochenschrift (1946), 2014-02, Vol.139 (6), p.272

Miehlke, S

2014

Volltextzugriff (PDF)

Eosinophilic esophagitis - update - pathogenesis, diagnosis and therapy

Zeitschrift fur Gastroenterologie, 2014-03, Vol.52 (3), p.296

2014

Volltextzugriff (PDF)

S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021-013

Zeitschrift fur Gastroenterologie, 2014-11, Vol.52 (11), p.1299

2014

Volltextzugriff (PDF)

Oral budesonide therapy improves quality of life in patients with collagenous colitis

International journal of colorectal disease, 2005-07, Vol.20 (4), p.312-316

2005

Volltextzugriff (PDF)

S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease

Zeitschrift fur Gastroenterologie, 2016-04, Vol.54 (4), p.327

2016

Volltextzugriff (PDF)

Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy – a randomized, double‐blind, placebo‐controlled multicentre trial

Alimentary pharmacology & therapeutics, 2006-02, Vol.23 (4), p.473-479

2006

Volltextzugriff (PDF)

1 – 25 von 470

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(380)
Mit Volltextzugriff
(330)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(277)
Science & Technology
(223)
Life Sciences & Biomedicine
(220)
Male
(127)
Gastroenterology & Hepatology
(123)
Female
(118)
Middle Aged
(110)
Adult
(104)
Aged
(87)
Helicobacter Pylori
(63)
Biological And Medical Sciences
(61)
Medical Sciences
(61)
Treatment Outcome
(51)
Surgery
(38)
Gastroenterology And Hepatology
(34)
Orthopedics
(34)
Helicobacter Infections - Drug Therapy
(32)
Follow-Up Studies
(28)
Gastroenterology. Liver. Pancreas. Abdomen
(28)
Aged, 80 And Over
(27)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Peripheral blood eosinophils and other non‐invasive biomarkers can monitor treatment response in eosinophilic oesophagitis

The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract

Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis

Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018

Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group

Induction of Intestinal P-glycoprotein by St John's Wort Reduces the Oral Bioavailability of Talinolol

Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagus

Diagnostic and therapeutic management of helicobacter pylori: a survey among German gastroenterologists in private practice

Randomized trial of rifabutin‐based triple therapy and high‐dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin

Clinical symptom tool that raises the index of suspicion for eosinophilic oesophagitis in adults and drives earlier biopsy for definitive diagnosis

Letter: multivariate clinical model for eosinophilic oesophagitis – is this generalisable to a general population? Authors’ reply

Microscopic colitis: clinical presentation, treatment and outcome of 494 patients

Long‐term follow‐up of collagenous colitis after induction of clinical remission with budesonide

Less favorable clinical outcome after diagnostic and interventional double balloon enteroscopy in patients with suspected small-bowel bleeding?

Complete Remission of Primary High-Grade B-Cell Gastric Lymphoma After Cure of Helicobacter pylori Infection

Eosinophilic Esophagitis - Update - Pathogenesis, Diagnosis and Therapy

Microscopic colitis--new insights relevant to clinical practice

Successful treatment of Lichen planus esophagitis with topical budesonide

Intragastric acidity during administration of generic omeprazole or esomeprazole – a randomised, two‐way crossover study including CYP2C19 genotyping

Eosinophilic esophagitis

Eosinophilic esophagitis - update - pathogenesis, diagnosis and therapy

S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021-013

Oral budesonide therapy improves quality of life in patients with collagenous colitis

S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease

Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy – a randomized, double‐blind, placebo‐controlled multicentre trial

Suchergebnisse filtern